152 related articles for article (PubMed ID: 8243537)
1. L-deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfish.
Adeyemo OM; Youdim MB; Markey SP; Markey CJ; Pollard HB
Eur J Pharmacol; 1993 Aug; 240(2-3):185-93. PubMed ID: 8243537
[TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
3. A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP.
Pollard HB; Dhariwal K; Adeyemo OM; Markey CJ; Caohuy H; Levine M; Markey S; Youdim MB
FASEB J; 1992 Sep; 6(12):3108-16. PubMed ID: 1521741
[TBL] [Abstract][Full Text] [Related]
4. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
5. Interactions among deprenyl, clorgyline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on catecholamines in mice.
Lee EH; Yang YL; Chia LG; Kuo JS
Neurosci Lett; 1994 Jan; 165(1-2):149-52. PubMed ID: 7912414
[TBL] [Abstract][Full Text] [Related]
6. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
7. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
[TBL] [Abstract][Full Text] [Related]
8. Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro.
Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
J Neural Transm Suppl; 1986; 22():55-60. PubMed ID: 3097260
[TBL] [Abstract][Full Text] [Related]
9. Deprenyl alters behavior and caudate dopamine through an amphetamine-like action.
Okuda C; Segal DS; Kuczenski R
Pharmacol Biochem Behav; 1992 Dec; 43(4):1075-80. PubMed ID: 1475291
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
McKinley ET; Baranowski TC; Blavo DO; Cato C; Doan TN; Rubinstein AL
Brain Res Mol Brain Res; 2005 Nov; 141(2):128-37. PubMed ID: 16209898
[TBL] [Abstract][Full Text] [Related]
11. Selegiline can mediate neuronal rescue rather than neuronal protection.
Tatton WG
Mov Disord; 1993; 8 Suppl 1():S20-30. PubMed ID: 8302304
[TBL] [Abstract][Full Text] [Related]
12. The role of MAO in MPTP toxicity--a review.
Glover V; Gibb C; Sandler M
J Neural Transm Suppl; 1986; 20():65-76. PubMed ID: 3091762
[TBL] [Abstract][Full Text] [Related]
13. Selegiline and the prophylaxis of Parkinson's disease.
Sandler M; Willoughby J; Glover V; Gibb C
J Neural Transm Suppl; 1987; 25():35-43. PubMed ID: 3123604
[TBL] [Abstract][Full Text] [Related]
14. Toxicity of MPTP and structural analogs in clonal cell lines of neuronal origin expressing B type monoamine oxidase activity.
Buckman TD
Mol Chem Neuropathol; 1991 Oct; 15(2):87-102. PubMed ID: 1776993
[TBL] [Abstract][Full Text] [Related]
15. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
Andrews AM; Murphy DL
J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
[TBL] [Abstract][Full Text] [Related]
16. Effect of MPTP on dopaminergic neurons in the goldfish brain: a light and electron microscope study.
Goping G; Pollard HB; Adeyemo OM; Kuijpers GA
Brain Res; 1995 Jul; 687(1-2):35-52. PubMed ID: 7583312
[TBL] [Abstract][Full Text] [Related]
17. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
Itzhak Y; Mash D; Zhang SH; Stein I
Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
Azam M; Jain S; Baquer NZ
Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
[TBL] [Abstract][Full Text] [Related]
20. Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.
Gupta M; Wiener HL
Neurochem Res; 1995 Apr; 20(4):385-9. PubMed ID: 7544444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
